Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Shares Outstanding (Diluted Average) (2017 - 2021)

Historic Shares Outstanding (Diluted Average) for Pediatrix Medical (MD) over the last 9 years, with Q1 2021 value amounting to $85.5 million.

  • Pediatrix Medical's Shares Outstanding (Diluted Average) rose 325.12% to $85.5 million in Q1 2021 from the same period last year, while for Mar 2021 it was $85.5 million, marking a year-over-year increase of 325.12%. This contributed to the annual value of $85.1 million for FY2020, which is 127.48% up from last year.
  • According to the latest figures from Q1 2021, Pediatrix Medical's Shares Outstanding (Diluted Average) is $85.5 million, which was up 325.12% from $85.1 million recorded in Q4 2020.
  • Over the past 5 years, Pediatrix Medical's Shares Outstanding (Diluted Average) peaked at $93.5 million during Q2 2018, and registered a low of $82.8 million during Q1 2020.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $87.2 million, with a median of $85.3 million in 2020.
  • Per our database at Business Quant, Pediatrix Medical's Shares Outstanding (Diluted Average) crashed by 1052.08% in 2019 and then soared by 325.12% in 2021.
  • Quarter analysis of 5 years shows Pediatrix Medical's Shares Outstanding (Diluted Average) stood at $93.0 million in 2017, then fell by 1.45% to $91.6 million in 2018, then dropped by 8.29% to $84.0 million in 2019, then rose by 1.27% to $85.1 million in 2020, then increased by 0.48% to $85.5 million in 2021.
  • Its last three reported values are $85.5 million in Q1 2021, $85.1 million for Q4 2020, and $83.9 million during Q3 2020.